Cargando…

Bone loss in aseptic revision total knee arthroplasty: management and outcomes

BACKGROUND: Although several techniques and implants have been developed to address bone loss in revision total knee arthroplasty (rTKA), management of these defects remains challenging. This review article discusses the indications and management options of bone loss following total knee arthroplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieganowski, Thomas, Buchalter, Daniel B., Singh, Vivek, Mercuri, John J., Aggarwal, Vinay K., Rozell, Joshua C., Schwarzkopf, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208118/
https://www.ncbi.nlm.nih.gov/pubmed/35725586
http://dx.doi.org/10.1186/s43019-022-00158-y
_version_ 1784729672351744000
author Bieganowski, Thomas
Buchalter, Daniel B.
Singh, Vivek
Mercuri, John J.
Aggarwal, Vinay K.
Rozell, Joshua C.
Schwarzkopf, Ran
author_facet Bieganowski, Thomas
Buchalter, Daniel B.
Singh, Vivek
Mercuri, John J.
Aggarwal, Vinay K.
Rozell, Joshua C.
Schwarzkopf, Ran
author_sort Bieganowski, Thomas
collection PubMed
description BACKGROUND: Although several techniques and implants have been developed to address bone loss in revision total knee arthroplasty (rTKA), management of these defects remains challenging. This review article discusses the indications and management options of bone loss following total knee arthroplasty based on preoperative workup and intraoperative findings. MAIN TEXT: Various imaging modalities are available that can be augmented with intraoperative examination to provide a clear classification of a bony defect. For this reason, the Anderson Orthopaedic Research Institute (AORI) classification is frequently used to guide treatment. The AORI provides a reliable system by which surgeons can classify lesions based on their size and involvement of surrounding structures. AORI type I defects are managed with cement with or without screws as well as impaction bone grafting. For AORI type IIA lesions, wedge or block augmentation is available. For large defects encompassing AORI type IIB and type III defects, bulk allografts, cones, sleeves, and megaprostheses can be used in conjunction with intramedullary stems. CONCLUSIONS: Treatment of bone loss in rTKA continues to evolve as different techniques and approaches have been validated through short- and mid-term follow-up. Extensive preoperative planning with imaging, accurate intraoperative evaluation of the bone loss, and comprehensive understanding of all the implant options available for the bone loss are paramount to success.
format Online
Article
Text
id pubmed-9208118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92081182022-06-21 Bone loss in aseptic revision total knee arthroplasty: management and outcomes Bieganowski, Thomas Buchalter, Daniel B. Singh, Vivek Mercuri, John J. Aggarwal, Vinay K. Rozell, Joshua C. Schwarzkopf, Ran Knee Surg Relat Res Review Article BACKGROUND: Although several techniques and implants have been developed to address bone loss in revision total knee arthroplasty (rTKA), management of these defects remains challenging. This review article discusses the indications and management options of bone loss following total knee arthroplasty based on preoperative workup and intraoperative findings. MAIN TEXT: Various imaging modalities are available that can be augmented with intraoperative examination to provide a clear classification of a bony defect. For this reason, the Anderson Orthopaedic Research Institute (AORI) classification is frequently used to guide treatment. The AORI provides a reliable system by which surgeons can classify lesions based on their size and involvement of surrounding structures. AORI type I defects are managed with cement with or without screws as well as impaction bone grafting. For AORI type IIA lesions, wedge or block augmentation is available. For large defects encompassing AORI type IIB and type III defects, bulk allografts, cones, sleeves, and megaprostheses can be used in conjunction with intramedullary stems. CONCLUSIONS: Treatment of bone loss in rTKA continues to evolve as different techniques and approaches have been validated through short- and mid-term follow-up. Extensive preoperative planning with imaging, accurate intraoperative evaluation of the bone loss, and comprehensive understanding of all the implant options available for the bone loss are paramount to success. BioMed Central 2022-06-20 /pmc/articles/PMC9208118/ /pubmed/35725586 http://dx.doi.org/10.1186/s43019-022-00158-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review Article
Bieganowski, Thomas
Buchalter, Daniel B.
Singh, Vivek
Mercuri, John J.
Aggarwal, Vinay K.
Rozell, Joshua C.
Schwarzkopf, Ran
Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title_full Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title_fullStr Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title_full_unstemmed Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title_short Bone loss in aseptic revision total knee arthroplasty: management and outcomes
title_sort bone loss in aseptic revision total knee arthroplasty: management and outcomes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208118/
https://www.ncbi.nlm.nih.gov/pubmed/35725586
http://dx.doi.org/10.1186/s43019-022-00158-y
work_keys_str_mv AT bieganowskithomas bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT buchalterdanielb bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT singhvivek bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT mercurijohnj bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT aggarwalvinayk bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT rozelljoshuac bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes
AT schwarzkopfran bonelossinasepticrevisiontotalkneearthroplastymanagementandoutcomes